Valuation Divi's Laboratories Limited

Stocks

Market Closed - NSE India S.E. 15:05:07 16/09/2026 +04			5-day change	1st Jan Change
9,158.00 ^INR	-0.43%		-4.36%	+43.26%

08-01	Divi's Laboratories Limited, Q1 2027 Earnings Call, Aug 01, 2026
08-01	Divi's Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	1,168,606	749,511	914,619	1,533,201	1,578,742	2,431,161	-	-
Change	-	-35.86%	22.03%	67.63%	2.97%	53.99%	-	-
Enterprise Value (EV) ¹	1,140,454	707,412	874,849	1,496,091	1,544,672	2,396,162	2,386,308	2,374,176
Change	-	-37.97%	23.67%	71.01%	3.25%	55.12%	-0.41%	-0.51%
P/E	39.5x	41.1x	57.2x	70x	61.5x	74.9x	62.1x	51.4x
PBR	9.96x	5.87x	6.74x	10.3x	9.42x	12.8x	11.1x	9.54x
PEG	-	-1.1x	-4.7x	1.9x	3.6x	2.8x	3x	2.5x
Capitalization / Revenue	13x	9.65x	11.7x	16.4x	15x	19.3x	16.2x	13.6x
EV / Revenue	12.7x	9.11x	11.2x	16x	14.6x	19.1x	15.9x	13.3x
EV / EBITDA	29.4x	29.9x	39.7x	50.4x	44.9x	52.9x	43.3x	34.6x
EV / EBIT	31.9x	34.9x	47.9x	58.3x	51.9x	60.3x	49x	38.6x
EV / FCF	95.1x	35.6x	339x	696x	709x	192x	134x	103x
FCF Yield	1.05%	2.81%	0.29%	0.14%	0.14%	0.52%	0.75%	0.97%
Dividend per Share ²	30	30	30	30	30	35.38	38.88	47.42
Rate of return	0.68%	1.06%	0.87%	0.52%	0.5%	0.38%	0.42%	0.52%
EPS ²	111.5	68.69	60.27	82.53	96.75	122.8	148	179
Distribution rate	26.9%	43.7%	49.8%	36.4%	31%	28.8%	26.3%	26.5%
Net sales ¹	89,598	77,675	78,450	93,600	105,600	125,752	149,904	178,853
EBITDA ¹	38,819	23,678	22,050	29,680	34,410	45,288	55,085	68,685
EBIT ¹	35,704	20,246	18,270	25,660	29,780	39,735	48,747	61,515
Net income ¹	29,604	18,234	16,000	21,910	25,680	32,649	39,418	47,659
Net Debt ¹	-28,152	-42,098	-39,770	-37,110	-34,070	-34,999	-44,854	-56,985
Reference price ²	4,402.05	2,823.35	3,445.30	5,775.45	5,947.00	9,198.00	9,198.00	9,198.00
Nbr of stocks (in thousands)	265,469	265,469	265,469	265,469	265,469	265,469	-	-
Announcement Date	23/05/22	20/05/23	25/05/24	17/05/25	23/05/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
DIVI'S LABORATORIES LIMITED	74.89x	19.14x	53.14x	0.38%	25.46B
ELI LILLY AND COMPANY	32.3x	11.75x	23.82x	0.61%	1,013B
JOHNSON & JOHNSON	29.72x	6.61x	18.51x	2.01%	644B
ABBVIE INC.	33.26x	7.79x	16.1x	2.61%	465B
ROCHE HOLDING AG	19.53x	4.77x	11.83x	2.78%	352B
NOVARTIS AG	19.64x	5.13x	12.73x	3.13%	264B
ASTRAZENECA PLC	20.94x	4.32x	12.33x	2.04%	253B
AMGEN INC.	23.76x	6.28x	11.19x	2.69%	203B
NOVO NORDISK A/S	12.28x	4.47x	9.35x	4.09%	188B
GILEAD SCIENCES, INC.	-44.25x	6.45x	25.21x	2.25%	181B
Average	22.21x	7.67x	19.42x	2.26%	358.91B
Weighted average by Cap.	23.88x	7.71x	17.87x	2%